We don't know for sure — yet. Previous strains of COVID could cause eye-related symptoms, but there isn't enough scientific data available right now to say with certainty that delta does the same.
There have been isolated reports of delta infections causing eye symptoms, including one fully vaccinated Kentuckian who had bloodshot eyes and flu-like symptoms, and a five-year-old in Mississippi who showed signs of conjunctivitis.
Although not nearly as common as symptoms like cough and fever, other strains of the coronavirus were capable of causing:
It isn't a stretch to think that some delta infections are capable of causing similar eye symptoms, but, like other aspects of delta, we need to wait for more information.
While each infection is different, delta seems to be causing slightly different symptoms overall than earlier forms of COVID.
"It seems like cough and loss of smell are less common," said Dr. Inci Yildirim, a pediatric infectious disease specialist at Yale Medicine, in an article about the delta variant. "And headache, sore throat, runny nose and fever are present based on the most recent surveys in the U.K., where more than 90% of the cases are due to the Delta strain."
If a set of symptoms that includes runny nose, sore throat and headache sounds familiar, it's because many delta infection symptoms resemble a bad case of hay fever — seasonal allergies — more than any other strain.
This is where eye-related symptoms could get even more confusing.
If you have bad seasonal allergies, you probably know how much allergies can affect your eyes. Red, bloodshot eyes are a hallmark symptom; itchiness, watering and even blurry vision are also common.
And while "classic" COVID symptoms are becoming less common, they can still show up. Cough, loss of taste or smell, and certain gastrointestinal symptoms still occur, but they're becoming less likely.
The three most widely available COVID-19 vaccines — Pfizer, Moderna and Johnson & Johnson — will still protect you against the delta variant, but not as effectively as they did against previous strains. Fortunately, studies continue to show that these "breakthrough" cases are less common and less severe, on average.